Reported 1 day ago
Eric Beyrich, co-chief investment officer at Sound Income Strategies, believes that value stocks will see a resurgence in 2025 due to their performance advantages in high interest rate environments and significant valuation discrepancies in the market. He argues that while high-growth stocks have inflated valuations, stocks with more stable fundamentals will become more appealing, and specifically recommends Pfizer and GSK as solid investment options.
Source: YAHOO